Drreddys Laboratories traded at $55.92 this Friday June 24th, increasing $0.92 or 1.67 percent since the previous trading session. Looking back, over the last four weeks, Drreddys Laboratories gained 0.81 percent. Over the last 12 months, its price fell by 22.21 percent. Looking ahead, we forecast Drreddys Laboratories to be priced at 51.69 by the end of this quarter and at 47.38 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
55.92
Daily Change
1.67%
Yearly
-22.21%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 2.01 0.16 8.65% -82.13%
ANI Pharmaceuticals 28.91 1.69 6.21% -12.50%
Bayer 57.79 -0.75 -1.28% 11.59%
Cipla 934.00 0.65 0.07% -2.41%
Corcept Therapeutics 23.80 0.55 2.37% 4.66%
Catalent 109.61 0 0% 0.41%
Endo International 0.37 -0.02 -5.72% -92.53%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Hikma Pharmaceutical 1,637.00 90.50 5.85% -32.33%
Horizon Pharma 85.13 2.22 2.68% -11.25%
Jazz Pharmaceuticals 153.49 2.72 1.80% -15.24%
Lannett 0.58 -0.02 -3.35% -88.26%
Lonza Group 512.80 24.80 5.08% -22.42%
Novartis 80.60 2.37 3.03% -4.80%
Phibro Animal Health 20.30 1.34 7.07% -28.65%
Prestige Brands 58.90 2.23 3.94% 11.47%
Pacira 57.43 1.15 2.04% -9.59%
Powershares High Yield Orate Bond Portfolio 17.10 0.10 0.59% -12.31%
Drreddys Laboratories 55.92 0.92 1.67% -22.21%
Richter Gedeon 6,850.00 -155.00 -2.21% -13.51%
Sun Pharmaceuticals 823.50 -1.40 -0.17% 22.50%
Supernus Pharmaceuticals 28.40 0.01 0.04% -13.04%
Teva Pharmaceutical Industries Ltd 2,677.00 18.00 0.68% -20.07%
United States Oil Fund 81.27 2.29 2.90% 61.73%
Canopy Growth Corp 4.88 0.20 4.27% -83.93%


Drreddys Laboratories
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.